AIMarketStockFuturesEarnSuper IPOMore
RPRX logo

RPRX (RPRX)

Company Profile

Contact Information

Market News

  • Royalty Pharma acquires royalty interest in AstraZeneca’s cliramitug for up to $425 million from Neurimmune2026-07-22T11:05
  • Neurimmune sells a portion of its royalty interest in cliramitug to Royalty Pharma2026-07-22T10:50
  • Royalty Pharma declares third quarter 2026 dividend2026-07-17T20:15
  • Royalty Pharma declares third quarter 2026 dividend2026-07-17T20:15
  • Royalty Pharma to announce second quarter 2026 financial results on August 5, 20262026-07-15T20:15

Financial Highlights

loading